Monthly Archives: February 2018

FDA’s Strategic Policy Roadmap, Part 3 – Improving Health Care, Access Issues and Public Health

In the last installment we looked at the first part of the Strategic Roadmap – Addiction which specifically focused on opioids and nicotine. However, the next part of the FDA Strategic Policy Roadmap is less specific and instead is focused … Continue reading

Posted in FDA Policy | Comments Off on FDA’s Strategic Policy Roadmap, Part 3 – Improving Health Care, Access Issues and Public Health

When Public Policy and Medical Science Are Misaligned

Two announcements last week were in startling contrast. One was a scientific development that moves the needle forward, the other a policy announcement that tries to pull it back.  The first development came from Google AI researchers and a published … Continue reading

Posted in Current Affairs | Comments Off on When Public Policy and Medical Science Are Misaligned

Weekly Roundup 3.23.18

At least here in the mid-Atlantic region, the ground hog appears to have got it wrong, with a week that had quite moderate temperatures. In the herb garden, the chives have popped up, always a harbinger of Spring. I tried … Continue reading

Posted in Weekly Roundup | Comments Off on Weekly Roundup 3.23.18

Weekly Roundup 2.16.18

This week we had 70 degree temperatures and predictions of snow. It seems we are living in roller coaster times – at least for this month. For all the lovers out there, hope the Valentine’s Day was second to none. … Continue reading

Posted in Weekly Roundup | Comments Off on Weekly Roundup 2.16.18

FDA’s Strategic Policy Roadmap – Part 2 Addressing Addiction

With deaths rising each year, there is no question of the urgency that something needs to be done to address the opioid misuse epidemic in the United States. And in addition to mortality there are the lives touched by these … Continue reading

Posted in FDA Policy | Comments Off on FDA’s Strategic Policy Roadmap – Part 2 Addressing Addiction